MANILA, Sept 3 (Reuters) - The Philippines' Food and Drug Administration (FDA) on Friday approved the emergency use of Moderna's COVID-19 doses for children ages 12 to 17, the agency's chief said.
"With the Delta variant affecting a lot of children, the experts saw that the benefit of using the vaccine outweigh the risks," FDA Director General Rolando Enrique Domingo told a public briefing.
(Reporting by Neil Jerome Morales Editing by Shri Navaratnam)
((neiljerome.morales@thomsonreuters.com; +632 8841 8914;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments